Malaria Prophylaxis for Travel to South Africa
For adult travelers to malaria-transmission areas of South Africa, use mefloquine 250 mg weekly OR the combination of chloroquine 300 mg weekly plus proguanil 200 mg daily, starting one week before departure and continuing for four weeks after return.
Recommended Regimens
South Africa's malaria areas, particularly the northeastern regions including Kruger National Park and Mpumalanga Province bordering Mozambique and Zimbabwe, harbor chloroquine-resistant Plasmodium falciparum 1. The South African Department of Health specifically recommends either mefloquine alone or chloroquine-proguanil combination for high-risk periods (October to May) 1.
Primary Options:
Option 1: Mefloquine (Preferred for highest efficacy)
- Dose: 250 mg weekly
- Timing: Start 1 week before travel, continue weekly during travel, and for 4 weeks after leaving the malaria area 2
- Advantages: Provides superior protection compared to chloroquine-proguanil in areas with chloroquine-resistant falciparum malaria 2
Option 2: Chloroquine + Proguanil
- Dose: Chloroquine 300 mg base weekly PLUS proguanil 200 mg daily 2, 3
- Timing: Same schedule as mefloquine
- Advantages: Fewer neuropsychiatric side effects; serious adverse events are rare (deaths almost unknown) 2
- Limitation: Provides "substantial protection, though less than that provided by mefloquine" in chloroquine-resistant areas 2
Option 3: Doxycycline (Alternative)
- Dose: 100 mg daily
- Use when: Mefloquine contraindicated or not tolerated 1
- Caution: Photosensitivity risk—avoid prolonged sun exposure and use UVA-blocking sunscreens 4
Critical Implementation Points
Timing and Compliance
- Start prophylaxis 1 week before departure to establish habit and identify early side effects 2
- Continue for 4 weeks after return—most malaria deaths occur in non-compliant travelers 2
- Compliance is essential; most deaths occur in those who don't fully comply 2
Mefloquine Contraindications (Must Screen)
Do NOT use mefloquine if patient has:
- History of epilepsy or seizures
- Psychiatric disorder (depression, anxiety disorder, psychosis)
- Cardiac conduction abnormalities or taking beta-blockers
- Occupation requiring fine motor coordination (pilots)
- Pregnancy or planning pregnancy
- Known hypersensitivity to mefloquine 4
Neuropsychiatric effects occur in 0.01% (severe) but may be higher; 70% occur within first three doses 2. While concerning, this frequency is "not high enough to interfere with recommending mefloquine for areas with a high risk of highly chloroquine resistant falciparum malaria" 2.
Chloroquine-Proguanil Considerations
- Minor side effects: mouth ulcers, GI upset, skin eruptions, psoriasis worsening 2
- Proguanil has limited availability in some tropical areas 2
- Research from travelers to east, central, and southern Africa showed breakthrough rate of 2.8-6.0 per 1000 travelers per month—less than 1% failure rate 3
Mosquito Bite Prevention (Essential Adjunct)
No chemoprophylaxis provides 100% protection 2. Combine medication with:
- Permethrin-impregnated bed nets (0.2 g/m² every 6 months) 2
- DEET-containing repellents on exposed skin after sunset 2
- Long sleeves and trousers after sunset 2
- Screened rooms with knockdown insecticide spray 2
Common Pitfalls to Avoid
- Stopping prophylaxis early: The 4-week post-travel period is critical—most infections manifest during this time 2
- Assuming no risk: South Africa's game parks are high-risk areas with documented chloroquine resistance 1
- Ignoring mefloquine contraindications: Screen carefully for psychiatric and neurological history 4
- Relying solely on medication: Mosquito avoidance is equally important 2
Post-Travel Vigilance
Any fever within 1 year of return requires urgent malaria evaluation, even with perfect prophylaxis compliance 2. Protection is never 100%, and breakthrough infections occur with all regimens.
Evidence Quality Note
The available guidelines are from 1995 [2-2] and 1990 4, but remain the highest-quality guideline evidence provided. More recent research confirms chloroquine resistance in South African game parks 1 and validates the chloroquine-proguanil combination's continued effectiveness in southern Africa 3. The fundamental recommendations remain valid: mefloquine for highest efficacy, or chloroquine-proguanil as effective alternative with better tolerability profile.